Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.33B | 21.36B | 13.72B | 8.42B | 5.40B | 4.38B |
Gross Profit | 6.38B | 6.42B | 3.75B | 2.11B | 1.38B | 1.23B |
EBITDA | 2.37B | 4.35B | 1.93B | 819.00M | 562.83M | 405.01M |
Net Income | 454.00M | 2.03B | 784.00M | 255.71M | 241.42M | 148.00M |
Balance Sheet | ||||||
Total Assets | 40.45B | 31.52B | 19.21B | 9.02B | 4.79B | 3.47B |
Cash, Cash Equivalents and Short-Term Investments | 6.59B | 3.31B | 2.61B | 814.76M | 496.36M | 1.35B |
Total Debt | 22.82B | 20.11B | 11.20B | 6.60B | 3.03B | 2.04B |
Total Liabilities | 31.03B | 24.38B | 13.84B | 8.15B | 4.09B | 2.98B |
Stockholders Equity | 9.42B | 7.14B | 5.37B | 864.74M | 693.47M | 487.00M |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.94B | -741.00M | -78.18M | -392.99M | -209.21M |
Operating Cash Flow | 0.00 | 2.56B | 1.14B | 378.19M | 201.03M | 313.13M |
Investing Cash Flow | 0.00 | -5.66B | -2.04B | -633.05M | -648.06M | -551.00M |
Financing Cash Flow | 0.00 | 3.80B | 2.70B | 573.26M | 489.42M | -818.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥18.98B | 12.47 | 3.95% | 4.15% | -25.67% | ||
68 Neutral | ¥8.77B | 20.08 | ― | 10.60% | 15.70% | ||
66 Neutral | ¥9.80B | 13.31 | 1.49% | 20.50% | 62.39% | ||
63 Neutral | ¥5.95B | 2.91 | 3.25% | 0.91% | 856.87% | ||
63 Neutral | ¥8.78B | 15.87 | 1.44% | 21.97% | -20.94% | ||
49 Neutral | ¥22.29B | 159.73 | 2.84% | 29.51% | -175.29% | ||
46 Neutral | C$198.48M | -3.49 | -23.22% | 2.62% | 21.07% | -1.26% |
Sunwels Co., Ltd. is focusing on addressing societal challenges in healthcare and caregiving by establishing specialized facilities like the ‘PD House’ for Parkinson’s disease, aiming for a sustainable society. The company announced its financial highlights for the fiscal year ending March 2025, emphasizing its commitment to healthcare innovation and sustainability, which may enhance its industry positioning and stakeholder value.
SUNWELS Co.,Ltd. reported its non-consolidated financial results for the year ending March 31, 2025, showing a significant increase in net sales by 31.8% to 26,496 million yen. However, the company faced a substantial decline in profitability, with operating profit falling by 51.0% and ordinary profit decreasing by 77.4%, resulting in a net loss of 925 million yen. The financial results indicate challenges in maintaining profitability despite increased sales, and the company has decided not to issue dividends for the year. This financial performance could impact its market positioning and stakeholder confidence.